Espirometría

García‐Río, Francisco; Calle, Myriam; Burgos, Felip; Casán, Pere; Campo, Félix del; Gáldiz, Juan B.; Giner, Jordi; González-Mangado, Nicolás; Ortega, Francisco; Puente-Maestu, Luís

doi:10.1016/j.arbres.2013.04.001

Cited by 218 publications

(110 citation statements)

References 96 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Spirometry was performed at the LC diagnosis by a technician specialized in respiratory functional tests. It was carried out with a Masterlab pneumatic-type spirometer (Jaeger AG, Würzburg, Germany), using acceptability and reproducibility criteria from the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) [31] and the European Respiratory Society (ERS) [32] guidelines, with the 2012 multi-ethnic reference values for spirometry for the 3–95 year range [33]. A bronchodilator test was performed in all cases by administrating 400 µg of salbutamol in 4 puffs (100 µg per puff) at 30-s intervals.…”

Section: Methodsmentioning

confidence: 99%

Chronic Obstructive Pulmonary Disease in Lung Cancer Patients: Prevalence, Underdiagnosis, and Clinical Characterization

et al. 2018

View full text Add to dashboard Cite

Background: Lung cancer (LC) and chronic obstructive pulmonary disease (COPD) are associated with increased morbidity and mortality. The differential clinical and functional features among LC patients with or without COPD have not been defined. Objectives: The aims of this study were to examine the prevalence and underdiagnosis rate of COPD in LC patients and to compare the clinical and functional features of LC patients with and without COPD. Methods: We designed a multicenter hospital-based study including all LC cases diagnosed from January 2014 to August 2016. We assessed epidemiological, clinical, radiological, functional, and histological variables in all cases. Results: We recruited 602 patients with LC, most of them men (77.9%), with a median age of 67 ± 15 years. The COPD prevalence among LC patients was 51.5%, with a underdiagnosis rate of 71.6%. The LC+COPD patients were older and the proportion of men was higher compared with the LC-only patients. The LC+COPD patients had more pack-years, more squamous LC, a lower monoxide transfer coefficient (KCO), and higher Charlson index scores than patients with LC only. The median survival of LC-only patients was 37% longer than that of LC+COPD patients (22 vs. 16 months), but this difference was not statistically significant. Conclusions: Among LC patients, COPD is prevalent and underdiagnosed. Patients with LC+COPD more often have squamous LC, have greater comorbidities, and have a lower KCO. More effort should be made for an early diagnosis of COPD to select patients at higher risk of developing LC.

show abstract

Section: Methodsmentioning

confidence: 99%

Chronic Obstructive Pulmonary Disease in Lung Cancer Patients: Prevalence, Underdiagnosis, and Clinical Characterization

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Spirometry was performed using a Datospir 500 (Sibelmed SA, Barcelona, Spain) following the recommendations of the European Respiratory Society [13] and the Spanish Respiratory Society (SEPAR) [14]. Patients were classified into two groups: those with an FEV 1 level ≥80% and those with an FEV 1 level <80%.…”

Section: Methodsmentioning

confidence: 99%

Usefulness of the Exhaled Breath Temperature Plateau in Asthma Patients

Lessmann

Giner

Torrego³

et al. 2015

Respiration

Self Cite

View full text Add to dashboard Cite

Background: Exhaled breath temperature (EBT) has recently been proposed as a noninvasive marker of bronchial inflammation in patients with asthma. However, the usefulness of EBT in everyday clinical practice is not well established. Results to date are contradictory and are mainly derived from small, pediatric populations. A comparison of results is further complicated by the use of different equipment and measurements. Objective: We performed a comprehensive study to determine whether EBT is related to asthma control, disease severity, bronchial obstruction, or bronchial inflammation. Methods: Sixty-nine patients on maintenance treatment for asthma were included in a cross-sectional study. At the same visit, we measured the EBT plateau (EBTp) using an X-halo Breath Thermometer (Delmedica, Singapore), the fraction of exhaled nitric oxide (FeNO), spirometry, and inflammatory cell count in induced sputum, and we administered the Asthma Control Test questionnaire. Results: No significant differences were found between EBTp measurements and the level of asthma control, disease severity, bronchial obstruction, FeNO levels, or inflammatory asthma phenotypes. We found a significant difference between EBTp and gender. The EBTp was 34.07°C (SD 0.74) in women and 34.38°C (0.46) in men (p = 0.038). We also found a significant correlation between EBTp measurements and the induced sputum eosinophil count (R = -0.348, p = 0.003). Conclusions: The results of this study do not support the usefulness of the EBTp in asthma management in routine clinical practice. Further research using standardized methods is needed to determine the potential use of the EBTp measurement in asthma management.

show abstract

“…Al comparar las características de los pacientes con enfisema secundario a DAAT y con EPOC se observaron como únicas diferencias que los pacientes con DAAT tenían una edad media menor (43 [7,7] frente a 53,6 [6,1] años; p < 0,001), un consumo de tabaco más bajo (23, 9 [15] vs. 50 [29] paquetes/año; p = 0,002) y una PCO 2 inferior (41,7 [7,6] vs. 47,9 [9,7] mmHg; p = 0,004) (tabla 2). …”

Section: Resultsunclassified

“…Las pruebas de función respiratoria se realizaron mediante el sistema Masterlab (MasterLab, Jaegger, Alemania), siguiendo las recomendaciones de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR) 6 . Se utilizó la prueba de marcha de 6 min para evaluar la capacidad de ejercicio.…”

Section: Métodounclassified